ALBANY — Health insurers that offer Medicare Advantage plans to seniors cheered a Trump administration decision announced ...

“Modifications like walk-in tubs, built-in shower benches, grab bars, pull-down cabinet shelves, and tap-to-open drawers are ...

The Congressional Budget Office had previously estimated that expanding Medicare coverage to anti-obesity medications could add up to $35 billion over the next decade, even after factoring in ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded coverage of costly anti-obesity drugs to more than 7 million Americans on ...

The Trump administration canceled a Biden-era plan on Friday that would have made Ozempic and other weight-loss drugs ...

The Trump administration finalized new policies for some Medicare programs on Friday, but left out provisions that would have ...

Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage cover various diabetes-related costs, including Trulicity. Out-of-pocket costs may apply.

The Trump administration said Friday that Medicare and Medicaid won’t expand coverage of popular anti-obesity drugs, rejecting a proposal issued late last year by the Biden administration.

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal ...

Catherine Howden, a spokeswoman for the Centers for Medicare and Medicaid Services, said in an email that the agency believed that expanding coverage “is not appropriate at this time.” ...

Former heart surgeon and TV pitchman Dr. Mehmet Oz was confirmed Thursday to lead the Centers for Medicare and Medicaid ...

The Centers for Medicare & Medicaid Services on Friday rejected a Biden administration proposal to expand Medicare coverage of weight-loss drugs such as Eli Lilly's Zepbound and Novo Nordisk's ...